Ketanserin (+)-tartrate salt
SIGMA/S006 - ≥97%, solid
Synonym: 3-
CAS Number: 83846-83-7
Empirical Formula (Hill Notation): C22H22FN3O3 · C4H6O6
Molecular Weight: 545.51
EC Number: 281-062-8
MDL Number: MFCD00084651
Linear Formula: C22H22FN3O3 · C4H6O6
Product Type: Chemical
| assay | ≥97% |
| color | white |
| form | solid |
| InChI | 1S/C22H22FN3O3.C4H6O6/c23 |
| InChI key | KMTLTEVOQLMYRS-LREBCSMRSA |
| Quality Level | 100 ![]() |
| SMILES string | O[C@H]([C@@H](O)C(O)=O)C( |
| solubility | 0.1 M HCl: 6 mg/mL (lit.)(lit.) |
| DMSO: 52 mg/mL (lit.)(lit.) | |
| ethanol: 3 mg/mL | |
| storage temp. | 2-8°C |
| Application: | Ketanserin (+)-tartrate salt has been used: • as a 5HT2A antagonist in Krebs-Henseleit buffer solution • for hormonal treatment to study the effects of exogenous manipulation of different hormonal systems in interaction with parasite infection on client′s behavior • to study the behavioural changes of incision pain rats |
| Biochem/physiol Actions: | Ketanserin stimulates collagen synthesis and is involved in wound healing. |
| Biochem/physiol Actions: | Selective 5-HT2 serotonin receptor antagonist. |
| Biochem/physiol Actions: | Selective 5-HT2 serotonin receptor antagonist. Ketanserin significantly reduces nicotine self-administration in rats, supporting an unexpected involvement of serotonin in nicotine addiction. |
| Packaging: | 10, 50 mg in glass bottle |
| Packaging: | 250, 500 mg in poly bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 22-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352202 |


